Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |